Publicaciones en las que colabora con HOURIA BOULAIZ TASSI (38)

2014

  1. Erratum: A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin (BioDrugs DOI : 10.1007/s40259-013-0055-0)

    BioDrugs

  2. Qualitative and quantitative analyses of anatomists' research: Evaluation of multidisciplinarity and trends in scientific production

    Scientometrics, Vol. 98, Núm. 1, pp. 447-456

2013

  1. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing

    BioMed Research International, Vol. 2013

2012

  1. 5-Fluorouracil derivatives: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 22, Núm. 2, pp. 107-123

  2. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells

    Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567

  3. How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment

    Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888

  4. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

    Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 (Springer Netherlands), pp. 157-171

2011

  1. Development of patents and clinical trials on regenerative therapy: Gene therapy

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 182-194

  2. Nanomedicine: Application areas and development prospects

    International Journal of Molecular Sciences, Vol. 12, Núm. 5, pp. 3303-3321

  3. Regenerative therapies in cartilage and bone: Current patents, technologies, and emerging applications

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 134-141

  4. gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway

    International Journal of Molecular Sciences, Vol. 12, Núm. 11, pp. 7445-7458

2010

  1. Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation

    Cells Tissues Organs, Vol. 191, Núm. 6, pp. 478-488

  2. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells

    Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 1, pp. 69-78

  3. Promotion of human adipose-derived stem cell proliferation mediated by exogenous nucleosides

    Cell Biology International, Vol. 34, Núm. 9, pp. 917-924

  4. Regression of established subcutaneous B16-F10 murine melanoma tumors after gef gene therapy associated with the mitochondrial apoptotic pathway

    Experimental Dermatology, Vol. 19, Núm. 4, pp. 363-371

  5. Release of muscle α-actin into serum after intensive exercise

    Biology of Sport, Vol. 27, Núm. 4, pp. 263-268

2009

  1. The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo

    Journal of Molecular Medicine, Vol. 87, Núm. 9, pp. 899-911

2008

  1. Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells

    International Journal of Oncology, Vol. 33, Núm. 1, pp. 121-127

  2. Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells

    British Journal of Dermatology, Vol. 159, Núm. 2, pp. 370-378

2007

  1. Anatomy teaching to physiotherapy students: Preliminary study in the European higher education area setting

    European Journal of Anatomy